Related Experiment Videos

Erythrocyte phosphoglycerate kinase deficiency: enzymatic and oxygen binding studies

Australian and New Zealand Journal of Medicine
|December 1, 1980
PubMed

Insights

X-linked phosphoglycerate kinase (PGK) deficiency causes severe neurological damage in males and hemolytic anemia in both sexes. Compensatory increases in 2,3-diphosphoglycerate improve oxygen delivery, except during crises.

Area of Science:

  • Biochemistry
  • Genetics
  • Hematology

Background:

  • Phosphoglycerate kinase (PGK) is an X-linked enzyme crucial for red blood cell energy metabolism.
  • Deficiency in red cell PGK can lead to hemolytic anemia and neurological complications.

Purpose of the Study:

  • To investigate the clinical manifestations and red blood cell physiology in a kindred with phosphoglycerate kinase deficiency.
  • To understand the impact of PGK deficiency on oxygen transport and red cell metabolism.

Main Methods:

  • Enzyme activity assays for phosphoglycerate kinase (PGK) in red blood cells.
  • Oxygen-hemoglobin equilibrium curve analysis.
  • Measurement of red blood cell ATP and 2,3-diphosphoglycerate (2,3-DPG) levels.

Main Results:

  • Affected males exhibited severe neurological damage, minimal PGK activity, hemolytic anemia, and decreased red cell ATP.
  • Both affected males and older heterozygotes showed elevated red cell 2,3-DPG levels and rightward shifts in oxygen-hemoglobin equilibrium curves.
  • Older heterozygotes presented with moderate hemolytic anemia and reduced PGK activity, while a younger heterozygote showed minimal abnormalities.

Conclusions:

  • Red cell PGK deficiency is a severe X-linked disorder with variable expressivity in heterozygotes.
  • Elevated 2,3-DPG compensates for impaired oxygen delivery in PGK deficiency, mitigating symptoms except during hemolytic crises.

Related Concept Videos